Header cover image

U.S. Pharmaceuticals & Biotech Spotless Management

Results

1

0 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

1 companies

Gilead Sciences

Market Cap: US$161.5b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

GILD

US$131.70

7D

-3.0%

1Y

19.9%